Alexis Borisy's Net Worth

$141 Million

Estimate Recalculated Nov 11, 2024 01:40PM EST

Who is Alexis Borisy

Alexis Borisy has an estimated net worth of $141 Million. This is based on reported shares across multiple companies, which include Revolution Medicines, Inc., Editas Medicine, Inc., Tango Therapeutics, Inc., Blueprint Medicines Corp, EQRx, Inc., Relay Therapeutics, Inc., Foundation Medicine, Inc., Magenta Therapeutics, Inc., OPKO HEALTH, INC., and COMBINATORX, INC.

SEC CIK

Alexis Borisy's CIK is 0001319446

Past Insider Trading and Trends

2021 was Alexis Borisy's most active year for acquiring shares with 13 total transactions. Alexis Borisy's most active month to acquire stocks was the month of May. 2006 was Alexis Borisy's most active year for disposing of shares, totalling 20 transactions. Alexis Borisy's most active month to dispose stocks was the month of June. 2019 saw Alexis Borisy paying a total of $715,084.95 for 46,193 shares, this is the most they've acquired in one year. In 2015 Alexis Borisy cashed out on 476,310 shares for a total of $23,815,500.00, their largest year based on trade value.

Loading...

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Revolution Medicines, Inc.

Investor
Updated Jun 28, 2024
Form 4/A
0.87%
20.20K
Jun 28, 2024
2.35M
Grant
Jun 20
Form 4
0.92%
21.50K
Jun 24, 2024
2.35M
Grant
Jun 20
Form 4
995.62%
2.39M
Nov 14, 2023
2.63M
Grant
Nov 09
Form 4
10.06%
23.60K
Jun 12, 2023
258.22K
Grant
Jun 08
Form 4
47.47%
23.60K
Jun 17, 2022
73.32K
Grant
Jun 16
Form 4
35.31%
16.28K
Jun 24, 2021
62.38K
Grant
Jun 22
Form 4
8.14K
Jun 19, 2020
8.14K
Grant
Jun 17
Form 3
Feb 12, 2020
Showing 8 results

Editas Medicine, Inc.

Investor
Updated Jun 19, 2017
Form 4
11.54K
Jun 19, 2017
11.54K
Grant
Jun 15
Form 4
Feb 09, 2016
Options
Feb 08
Form 3
Feb 02, 2016
Showing 3 results

Tango Therapeutics, Inc.

Investor
Updated Jun 07, 2024
Form 4
875.00%
43.75K
Jun 07, 2024
48.75K
Grant
Jun 05
Form 4
35.00K
Jun 08, 2023
35.00K
Grant
Jun 06
Form 4
40.00K
Jun 28, 2022
40.00K
Grant
Jun 08
Form 3
Aug 12, 2021
Showing 4 results

Blueprint Medicines Corp

Investor
Updated Jun 14, 2024
Form 4
9.47%
6.81K
Jun 14, 2024
78.73K
Grant
Jun 12
Form 4
11.40%
7.90K
Jun 23, 2023
77.22K
Grant
Jun 21
Form 4
11.84%
7.90K
Jun 30, 2022
74.62K
Grant
Jun 21
Form 4
10.47%
6.75K
Jun 04, 2021
71.22K
Grant
Jun 02
Form 4
10.85%
6.75K
Jun 26, 2020
68.97K
Grant
Jun 24
Form 4
Jun 23, 2020
62.22K
Options
Jun 19
Form 4
-26.37%
-21.82K
$62.40
-$1.29M
Jul 01, 2019
60.91K
Sale
Jun 27
Form 4
6.19K
Jun 20, 2019
6.19K
Grant
Jun 19
Form 4
34.38%
7.50K
Jun 25, 2018
29.32K
Grant
Jun 21
Form 4
May 14, 2018
53.25K
s
May 10 - May 11
Form 4
May 11, 2018
53.25K
s
May 09
Form 4
May 08, 2018
53.25K
s
May 04 - May 07
Form 4
100.00%
10.91K
Jun 23, 2017
21.82K
Grant
Jun 21
Form 4
Feb 09, 2017
40.84K
s
Feb 07
Form 4
10.91K
Jun 27, 2016
10.91K
Grant
Jun 23
Form 4
47.09%
8.56K
Dec 02, 2015
26.74K
Acquisition
Nov 18
Form 3
Apr 30, 2015
18.18K
Showing 17 results

EQRx, Inc.

Executive Chairman
Updated Nov 09, 2023
Form 4
-100.00%
-23.90M
Nov 09, 2023
Disposition
Nov 09
Form 4
0.53%
15.15K
Jan 04, 2023
2.89M
Grant
Jan 01
Form 4
23.88M
Dec 21, 2021
23.88M
Grant
Dec 17
Form 3
Dec 20, 2021
Showing 4 results

Relay Therapeutics, Inc.

Investor
Updated Jun 05, 2024
Form 4
102.22K
Jun 05, 2024
102.23K
Grant
Jun 03
Form 4
66.06K
Jun 01, 2023
66.06K
Grant
May 31
Form 4
41.60K
May 27, 2022
41.60K
Grant
May 27
Form 4
16.00K
May 21, 2021
16.00K
Grant
May 19
Form 4
13.88%
28.54K
Mar 25, 2021
234.18K
Acquisition
Mar 11
Form 4
17.21%
30.19K
Feb 19, 2021
205.64K
Acquisition
Feb 19
Form 4
67.91%
70.96K
Feb 09, 2021
175.44K
Acquisition
Feb 05
Form 4
-71.84%
-266.54K
Jul 21, 2020
104.49K
Options
Jul 20
Form 3
Jul 15, 2020
Showing 9 results

Foundation Medicine, Inc.

Investor
Updated Aug 02, 2018
Form 4
-100.00%
-86.56K
$137.00
-$10.02M
Aug 02, 2018
Options
Jul 31
Form 4
8.59%
5.79K
$40.05
$231.73K
Jun 22, 2017
73.17K
Grant
Jun 20
Form 4
21.83%
12.07K
$19.93
$240.65K
Jun 20, 2016
67.39K
Grant
Jun 16
Form 4
12.16%
6.00K
$32.23
$193.28K
Jun 22, 2015
55.31K
Grant
Jun 18
Form 4
0.92%
448.00
May 15, 2015
49.32K
Acquisition
May 14
Form 4/A
-83.19%
-241.77K
$50.00
-$12.09M
Apr 16, 2015
48.87K
Sale
Apr 07
Form 4
-80.70%
-234.54K
$50.00
-$11.73M
Apr 09, 2015
56.09K
Sale
Apr 07
Form 4
13.38K
Jun 20, 2014
13.39K
Grant
Jun 18
Form 4
0.00%
10.00
May 14, 2014
290.64K
Acquisition
May 12
Form 4
-73.96%
-18.66M
Oct 02, 2013
6.57M
Options
Sep 30
Form 3
Sep 24, 2013
290.63K
Showing 11 results

Magenta Therapeutics, Inc.

Investor
Updated Sep 23, 2021
Form 4
4.10K
Sep 23, 2021
4.10K
Acq/Dis
Aug 26
Form 4
18.19K
Jun 03, 2021
18.19K
Grant
Jun 01
Form 4
18.19K
Jun 09, 2020
18.19K
Grant
Jun 05
Form 4
18.19K
Jun 11, 2019
18.19K
Grant
Jun 07
Form 4
Jun 27, 2018
Options
Jun 25
Form 3
Jun 20, 2018
Showing 6 results

OPKO HEALTH, INC.

Investor
Updated Jun 23, 2023
Form 4
30.00K
Jun 23, 2023
30.00K
Grant
Jun 22
Form 4
-50.00%
-30.00K
Jul 15, 2022
30.00K
Grant
Jul 14
Form 4/A
362.61K
May 13, 2022
362.61K
Grant
May 09
Form 4
362.61K
May 11, 2022
362.61K
Grant
May 09
Form 3
May 11, 2022
Showing 5 results

COMBINATORX, INC

CEO & President
Updated Jan 28, 2009
Form 4
-1.66%
-5.26K
$0.63
-$3.30K
Jan 28, 2009
312.20K
Sale
ScheduledJan 26
Form 4
152.50K
Jul 17, 2008
152.50K
Grant
Jul 15
Form 4
-1.23%
-3.97K
$5.15
-$20.44K
Jan 29, 2008
317.46K
Tax
Jan 26
Form 4
255.00K
Jan 17, 2008
255.00K
Grant
Jan 15
Form 4
50.00K
Jul 13, 2007
50.00K
Grant
Jul 11
Form 4
150.00K
Jan 19, 2007
150.00K
Grant
Jan 17
Form 4
-2.80%
-10.00K
$4.27
-$68.00K
Jul 24, 2006
347.14K
Sale
ScheduledJul 20
Form 4
50.00K
Jul 14, 2006
50.00K
Grant
Jul 12
Form 4
-2.72%
-10.00K
$4.94
-$81.54K
Jul 07, 2006
357.14K
Sale
ScheduledJul 05
Form 4
18.42%
50.00K
Jan 30, 2006
321.43K
Grant
Jan 26
Form 4
200.00K
Dec 19, 2005
200.00K
Grant
Dec 15
Form 3
Nov 09, 2005
271.43K
Showing 12 results